hydralazine has been researched along with sulfasalazine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Drayer, DE; Reidenberg, MM | 1 |
| Alarcón-Segovia, D; Kraus, A | 1 |
| Biarese, V; Cargnino, M; Lerda, R; Lovisetto, P; Mairano, D; Marchi, L | 1 |
| Clark, DW | 1 |
| Bernstein, RM; Clayton, AL; Hobbs, RN | 1 |
| Skakun, NP | 1 |
| Preisig, R | 1 |
| Choi, HK; Merkel, PA; Niles, JL; Walker, AM | 1 |
| Handler, J | 1 |
| Aklillu, E; Altman, RB; Boukouvala, S; Hein, DW; Klein, TE; McDonagh, EM | 1 |
6 review(s) available for hydralazine and sulfasalazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug-related lupus syndromes and their relationship to spontaneously occurring systemic lupus erythematosus.
Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Hydralazine; Lupus Erythematosus, Systemic; Practolol; Propylthiouracil; Quinidine; Sulfasalazine | 1991 |
[Drug-induced lupus].
Topics: Acetylation; Adrenergic beta-Antagonists; Antibodies, Antinuclear; Anticonvulsants; B-Lymphocytes; Diagnosis, Differential; HLA Antigens; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Lymphocyte Activation; Penicillamine; Procainamide; Sulfasalazine; T-Lymphocytes, Regulatory | 1985 |
Genetically determined variability in acetylation and oxidation. Therapeutic implications.
Topics: Acetylation; Anticonvulsants; Antidepressive Agents, Tricyclic; Debrisoquin; Disease; Drug Interactions; Genetic Variation; Humans; Hydralazine; Isoniazid; Oxidation-Reduction; Pharmaceutical Preparations; Phenelzine; Phenotype; Procainamide; Racial Groups; Sparteine; Sulfasalazine | 1985 |
[Pharmacokinetics of drug preparations metabolized by N-acetyltransferase].
Topics: Acetylation; Acetyltransferases; Dapsone; Humans; Hydralazine; Inactivation, Metabolic; Isoniazid; Kinetics; Liver; Pharmaceutical Preparations; Phenotype; Procainamide; Sulfamethazine; Sulfasalazine | 1982 |
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.
Topics: Alleles; Arylamine N-Acetyltransferase; Caffeine; Gene Expression Profiling; Genomics; Genotype; Humans; Hydralazine; Isoenzymes; Isoniazid; Pharmacogenetics; Phenotype; Polymorphism, Genetic; Sulfamethoxazole; Sulfasalazine; Xenobiotics | 2014 |
9 other study(ies) available for hydralazine and sulfasalazine
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Clinical consequences of polymorphic acetylation of basic drugs.
Topics: Acetylation; Antibodies, Antinuclear; Biotransformation; Chemical and Drug Induced Liver Injury; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Pharmaceutical Preparations; Phenelzine; Phenotype; Polymorphism, Genetic; Procainamide; Sulfasalazine | 1977 |
Antibodies to the five histones and poly(adenosine diphosphate-ribose) in drug induced lupus: implications for pathogenesis.
Topics: Antibodies, Antinuclear; Histones; Humans; Hydralazine; Lupus Erythematosus, Systemic; Nucleoside Diphosphate Sugars; Penicillamine; Poly Adenosine Diphosphate Ribose; Sulfasalazine | 1987 |
[Pharmacogenetics: light in the darkness of drug toxicity].
Topics: Acetylation; Biological Availability; Drug Combinations; Glucosamine; Humans; Hydralazine; Hydroxylation; Isoniazid; Liver; Pharmacogenetics; Receptors, Drug; Sulfasalazine | 1982 |
Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Antibodies; Antibodies, Antineutrophil Cytoplasmic; Female; Humans; Hydralazine; Male; Middle Aged; Penicillamine; Peroxidase; Propylthiouracil; Sulfasalazine; Vasculitis | 2000 |
Hydralazine-induced lupus erythematosis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Lupus Erythematosus, Systemic; Sulfasalazine | 2012 |